Overview

A Study of Risperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Participants With a History of Being Poorly Compliant With Taking Their Medication

Status:
Terminated

Trial end date:
2009-04-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate risperidone long-acting injection (an antipsychotic medication) versus oral antipsychotics in schizophrenia (psychiatric disorder with symptoms of emotional instability, detachment from reality, often with delusions and hallucinations, and withdrawal into the self) participants with a history of being poorly compliant with taking their medication.

Phase:

Phase 4

Details

Lead Sponsor:

Janssen-Ortho Inc., Canada

Treatments:

Antipsychotic Agents
Risperidone